EGFR and neoplasm: The skin metastasis sample showed a very similar pattern of alterations in driver genes as compared with the treated tumor, including the PIK3CA hotspot mutation, the amplifications in CCND1, EGFR, and FGFR3, and the deletions in CDK1B, CDKN2A, and CDKN2B.